脐带血移植：我们能否使其更完善？
Cord Blood Transplantation: Can We Make it Better?
作者信息
Metheny Leland, Caimi Paolo, de Lima Marcos
机构信息
Stem Cell Transplantation Program, University Hospitals Case Medical Center, Case Western Reserve University , Cleveland, OH , USA.
出版信息
Front Oncol. 2013 Sep 17;3:238. doi: 10.3389/fonc.2013.00238.
Abstract
Umbilical cord blood is an established source of hematopoietic stem cells for transplantation. It enjoys several advantages over bone marrow or peripheral blood, including increased tolerance for Human Leukocyte Antigen mismatches, decreased incidence of graft-versus-host disease, and easy availability. Unrelated cord blood does have limitations, however, especially in the treatment of adults. In the 24 years since the first umbilical cord blood transplant was performed, significant progress has been made, but delayed hematopoietic engraftment and increased treatment-related mortality remain obstacles to widespread use. Here we summarize the latest results of unrelated cord blood transplants, and review strategies under investigation to improve clinical outcomes.
摘要
脐带血是一种既定的用于移植的造血干细胞来源。与骨髓或外周血相比，它具有几个优势，包括对人类白细胞抗原不匹配的耐受性增加、移植物抗宿主病的发病率降低以及易于获取。然而，无关供者脐带血确实存在局限性，尤其是在成人治疗方面。自首次进行脐带血移植以来的24年里，已经取得了重大进展，但造血植入延迟和治疗相关死亡率增加仍然是广泛应用的障碍。在此，我们总结了无关供者脐带血移植的最新结果，并回顾了正在研究的改善临床结局的策略。
相似文献
1
Cord Blood Transplantation: Can We Make it Better?脐带血移植：我们能否使其更完善？
Front Oncol. 2013 Sep 17;3:238. doi: 10.3389/fonc.2013.00238.
2
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.与双脐带移植相比，减低强度单倍体加单脐带移植：植入改善，无移植物抗宿主病，无复发生存率提高。
Haematologica. 2016 May;101(5):634-43. doi: 10.3324/haematol.2015.138594. Epub 2016 Feb 11.
3
Results of unrelated umbilical cord blood hematopoietic stem cell transplantation.非亲缘脐血造血干细胞移植的结果
Rev Clin Exp Hematol. 2001 Jun;5(2):87-99. doi: 10.1046/j.1468-0734.2001.00034.x.
4
Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.弥漫性肺泡出血大多是致命的，受移植物来源、预处理方案毒性和植入动力学的影响。
Haematologica. 2018 Dec;103(12):2109-2115. doi: 10.3324/haematol.2018.189134. Epub 2018 Aug 3.
5
Current status of umbilical cord blood hematopoietic stem cell transplantation.脐带血造血干细胞移植的现状
Exp Hematol. 2000 Nov;28(11):1197-205. doi: 10.1016/s0301-472x(00)00540-3.
6
Umbilical cord blood transplantation: current state of the art.脐带血移植：当前技术水平
Curr Opin Oncol. 2002 Mar;14(2):160-4. doi: 10.1097/00001622-200203000-00004.
7
Advances in unrelated cord blood transplants in malignancies.恶性肿瘤中非血缘脐血移植的进展
Leuk Suppl. 2012 Aug;1(Suppl 2):S10-1. doi: 10.1038/leusup.2012.8. Epub 2012 Aug 9.
8
Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.非血缘供者造血干细胞移植治疗强化预处理方案后成熟淋巴系统恶性肿瘤：脐带血和无关供者外周血造血干细胞移植的结果相似。
Haematologica. 2014 Feb;99(2):370-7. doi: 10.3324/haematol.2013.088997. Epub 2013 Aug 9.
9
Clinical use of umbilical cord blood hematopoietic stem cells.脐带血造血干细胞的临床应用。
Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):34-41. doi: 10.1016/j.bbmt.2005.09.006.
10
[Umbilical cord blood as a source of stem cells].[脐带血作为干细胞的来源]
Acta Med Croatica. 2006 Jun;60(3):215-25.
引用本文的文献
1
Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood.围产组织间充质基质细胞作为从脐带血造血祖细胞和干细胞体外扩增的一种替代方法。
Int J Mol Sci. 2023 Oct 24;24(21):15544. doi: 10.3390/ijms242115544.
2
Microglia and Macrophages in Neuroprotection, Neurogenesis, and Emerging Therapies for Stroke.小胶质细胞和巨噬细胞在神经保护、神经发生和中风新兴疗法中的作用。
Cells. 2021 Dec 16;10(12):3555. doi: 10.3390/cells10123555.
3
The number of CD34CD133 hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34 cells: a possible new indicator for quality evaluation of UCB units.脐血（UCB）单位中CD34CD133造血干细胞的数量与总核细胞数和CD34细胞数无关：一种评估UCB单位质量的可能新指标。
Int J Hematol. 2018 Dec;108(6):571-579. doi: 10.1007/s12185-018-2502-7. Epub 2018 Jul 25.
4
Mesenchymal Stem Cell-Derived Microvesicles Support Ex Vivo Expansion of Cord Blood-Derived CD34(+) Cells.间充质干细胞衍生的微泡支持脐血来源的CD34(+)细胞的体外扩增。
Stem Cells Int. 2016;2016:6493241. doi: 10.1155/2016/6493241. Epub 2016 Mar 6.
5
In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic.用糖胺聚糖模拟物扩增的脐带血造血干细胞和祖细胞的体外和体内评估
Stem Cell Res Ther. 2016 Jan 7;7:3. doi: 10.1186/s13287-015-0267-y.
6
Correlation of ultrasound estimated placental volume and umbilical cord blood volume in term pregnancy.足月妊娠中超声估计胎盘体积与脐血容量的相关性
J Turk Ger Gynecol Assoc. 2015 Jun 1;16(2):64-7. doi: 10.5152/jtgga.2015.15235. eCollection 2015.
本文引用的文献
1
Cord-blood engraftment with ex vivo mesenchymal-cell coculture.体外间充质细胞共培养促进脐血植入。
N Engl J Med. 2012 Dec 13;367(24):2305-15. doi: 10.1056/NEJMoa1207285.
2
Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study.脐血干细胞骨内移植建立局部植入储备：一项PET/FDG功能研究
J Biomed Biotechnol. 2012;2012:767369. doi: 10.1155/2012/767369. Epub 2012 Oct 2.
3
Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.MSC 共给药和给药途径对脐血造血干细胞植入的影响。
Cell Transplant. 2013;22(7):1171-83. doi: 10.3727/096368912X657431. Epub 2012 Oct 2.
4
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.急性白血病的低强度预处理移植：无关供者干细胞来源对结局的影响。
Blood. 2012 Jun 7;119(23):5591-8. doi: 10.1182/blood-2011-12-400630. Epub 2012 Apr 10.
5
Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice.体外岩藻糖基化可改善人脐血在 NOD-SCID IL-2Rγ（null）小鼠中的植入。
Exp Hematol. 2012 Jun;40(6):445-56. doi: 10.1016/j.exphem.2012.01.015. Epub 2012 Feb 2.
6
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.前瞻性研究：在血液恶性肿瘤成人患者中，采用减低强度预处理方案进行单份与双份脐带血移植的效果比较。
Bone Marrow Transplant. 2012 Jul;47(7):924-33. doi: 10.1038/bmt.2011.195. Epub 2011 Oct 17.
7
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.供受者 HLA-A、B、C、DRB1 匹配对白血病和骨髓增生异常综合征患者脐血移植后结局的影响：一项回顾性分析。
Lancet Oncol. 2011 Dec;12(13):1214-21. doi: 10.1016/S1470-2045(11)70260-1. Epub 2011 Oct 6.
8
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.采用亲缘单倍体相合联合脐带血移植的减低强度预处理方案可实现快速植入、低移植物抗宿主病发生率和持久缓解。
Blood. 2011 Dec 8;118(24):6438-45. doi: 10.1182/blood-2011-08-372508. Epub 2011 Oct 5.
9
How I treat: the selection and acquisition of unrelated cord blood grafts.我如何治疗：无关脐带血移植物的选择和获取。
Blood. 2011 Feb 24;117(8):2332-9. doi: 10.1182/blood-2010-04-280966. Epub 2010 Dec 13.
10
Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.输注细胞剂量和 HLA 配型对双份脐血移植后植入的影响。
Blood. 2011 Mar 24;117(12):3277-85; quiz 3478. doi: 10.1182/blood-2010-08-300491. Epub 2010 Dec 13.
Zotero 插件